National Institute on Drug Abuse; Notice of Closed Meetings, 7319-7320 [2020-02403]
Download as PDF
<![CDATA[
7319
Federal Register / Vol. 85, No. 26 / Friday, February 7, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Type of
respondents
BUILD Institutional Research & Program
Data Requests (Attachment 19).
BUILD Site Visits (Attachment 18) ............
(Attach-
Personnel and Administrators
at BUILD Institutions.
BUILD Students, Faculty, and
Institution.
BUILD Students, Faculty, and
Institutions.
Undergraduate BUILD Students.
Graduate/post-doctoral BUILD
students.
BUILD PI’s, Program Managers/Directors, & Faculty.
NRMN 2020 mentee cohort .....
(Attach-
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hours
10
3
16
480
120
1
24
2,880
24
1
40
960
170
1
90/60
255
70
1
90/60
105
162
1
90/60
243
500
3
25/60
625
NRMN 2021 mentee cohort .....
500
3
25/60
625
(Attach-
NRMN 2022 mentee cohort .....
500
2
25/60
417
(Attach-
NRMN 2020 mentor cohort ......
500
3
25/60
625
(Attach-
NRMN 2021 mentor cohort ......
500
3
25/60
625
(Attach-
NRMN 2022 mentor cohort ......
500
2
25/60
417
Total ...................................................
..................................................
64,556
85,076
........................
55,132
BUILD Case Studies Preparation
ment 18).
BUILD Case Study Interviews
ment 18).
BUILD Case Study Interviews
ment 18).
BUILD Case Study Interviews
ment 18).
NRMN Annual Follow-up Surveys
ment 17).
NRMN Annual Follow-up Surveys
ment 17).
NRMN Annual Follow-up Surveys
ment 17).
NRMN Annual Follow-up Surveys
ment 17).
NRMN Annual Follow-up Surveys
ment 17).
NRMN Annual Follow-up Surveys
ment 17).
(Attach(Attach(Attach(Attach-
Dated: January 28, 2020.
Richard A. Aragon,
Project Clearance Liaison, National Institute
of General Medical Sciences, National
Institutes of Health.
[FR Doc. 2020–02457 Filed 2–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: NIGMS Initial Review
Group; Training and Workforce Development
Subcommittee—B Review of Predoctoral
Training Grant Applications.
VerDate Sep<11>2014
17:42 Feb 06, 2020
Jkt 250001
Date: March 9, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites—Chevy Chase
Pavilion, Conference room Chevy Chase
ballroom, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, Office of Scientific
Review, National Institutes of General
Medical Sciences, National Institutes of
Health, 45 Center Drive, Room 3AN18A,
Bethesda, MD 20814, (301) 435–0965,
newmanla2@mail.nih.gov.
Name of Committee: NIGMS Initial Review
Group; Training and Workforce Development
Subcommittee—A.
Date: March 20, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Plaza Hotel, Conference
room Grand Ballroom B & C, 10 Thomas
Circle, NW Washington, DC 20005.
Contact Person: John J. Laffan, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health,
Natcher Building, Room 3AN18J, Bethesda,
MD 20892, (301) 594–2773, laffanjo@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 3, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–02404 Filed 2–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel;
Leveraging Big Data Science to Elucidate the
E:\FR\FM\07FEN1.SGM
07FEN1
jbell on DSKJLSW7X2PROD with NOTICES
7320
Federal Register / Vol. 85, No. 26 / Friday, February 7, 2020 / Notices
Mechanisms of HIV Activity and Interaction
with Substance Use Disorder.
Date: March 5, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Science Center, 6001 Executive
Boulevard, Room 4238, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Hiromi Ono, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, Room 4238, MSC
9550, Bethesda, MD 20892, 301–402–6020,
hiromi.ono@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIDA
Core and Research Center of Excellence Grant
Program (P30/50 Clinical Trial Optional).
Date: March 9–10, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott Bethesda Chevy
Chase, 5520 Wisconsin Avenue, Chevy
Chase, MD 20815.
Contact Person: Yvonne Owens Ferguson,
Ph.D., Scientific Review Officer, Office of
Extramural Policy and Review, Division of
Extramural Research, National Institute on
Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, Room 4234,
Bethesda, MD 20892, 301–402–7371,
yvonne.ferguson@nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; NIH
Pathway to Independence Award (K99/R00).
Date: March 19, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Science Center, 6001 Executive
Boulevard, Room 4229, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer, Office of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Alcohol
and Other Substance Use Research Education
Programs for Health Professionals (R25
Clinical Trial Not Allowed).
Date: April 6, 2020.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Science Center, 6001 Executive
Boulevard, Room 4229, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Susan O. McGuire, Ph.D.,
Scientific Review Officer Office, of
Extramural Affairs, National Institute on
Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, Room 4245,
Rockville, MD 20852, 301–435–1426,
mcguireso@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
VerDate Sep<11>2014
17:42 Feb 06, 2020
Jkt 250001
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: February 3, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–02403 Filed 2–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; To review NIH Pathway to
Independence Award (K99/R00)
Applications.
Date: March 25, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, Conference
room: Congressional, One Bethesda Metro
Center, 7400 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Saraswathy Seetharam,
Scientific Review Officer, Office Scientific
Review, National Institute of General Medical
Sciences, National Institutes Health, 45
Center Drive, Room 3AN12C, Bethesda, MD
20892, (301) 594–2763, seetharams@
nigms.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Review of NIGMS MOSAIC UE5
Applications.
Date: March 27, 2020.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Room
Embassy, 45 Center Drive, Bethesda, MD
20892 (Virtual Meeting).
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, (301) 594–3907, pikebr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: February 3, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–02405 Filed 2–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review Amended;
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
Molecular and Cellular Endocrinology,
February 6, 2020, 11:30 a.m. to February
6, 12:30 p.m., which was published in
the Federal Register on January 13,
2020, 85 FR 1816.
The meeting location is being changed
to Melrose Hotel, 2430 Pennsylvania
Ave NW, Washington, DC 20037.
Meeting dates and time remain the
same. The meeting is closed to the
public.
Dated: February 3, 2020.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–02456 Filed 2–6–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
DEPARTMENT OF AGRICULTURE
Forest Service
Notice of Availability of the Bog Creek
Road Project Final Records of
Decision
U.S. Customs and Border
Protection, Department of Homeland
AGENCY:
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 85, Number 26 (Friday, February 7, 2020)]
[Notices]
[Pages 7319-7320]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02403]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Leveraging Big Data Science to Elucidate the
[[Page 7320]]
Mechanisms of HIV Activity and Interaction with Substance Use
Disorder.
Date: March 5, 2020.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Science Center,
6001 Executive Boulevard, Room 4238, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Hiromi Ono, Ph.D., Scientific Review Officer,
Office of Extramural Affairs, National Institute on Drug Abuse,
National Institutes of Health, 6001 Executive Boulevard, Room 4238,
MSC 9550, Bethesda, MD 20892, 301-402-6020, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIDA Core and Research Center of Excellence Grant
Program (P30/50 Clinical Trial Optional).
Date: March 9-10, 2020.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Marriott Bethesda Chevy Chase, 5520 Wisconsin
Avenue, Chevy Chase, MD 20815.
Contact Person: Yvonne Owens Ferguson, Ph.D., Scientific Review
Officer, Office of Extramural Policy and Review, Division of
Extramural Research, National Institute on Drug Abuse, National
Institutes of Health, 6001 Executive Boulevard, Room 4234, Bethesda,
MD 20892, 301-402-7371, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; NIH Pathway to Independence Award (K99/R00).
Date: March 19, 2020.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Science Center,
6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer, Office of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room
4245, Rockville, MD 20852, 301-435-1426, [email protected].
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel; Alcohol and Other Substance Use Research Education
Programs for Health Professionals (R25 Clinical Trial Not Allowed).
Date: April 6, 2020.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, National Science Center,
6001 Executive Boulevard, Room 4229, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Susan O. McGuire, Ph.D., Scientific Review
Officer Office, of Extramural Affairs, National Institute on Drug
Abuse, National Institutes of Health, 6001 Executive Boulevard, Room
4245, Rockville, MD 20852, 301-435-1426, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug
Abuse Scientist Development Award for Clinicians, Scientist
Development Awards, and Research Scientist Awards; 93.278, Drug
Abuse National Research Service Awards for Research Training;
93.279, Drug Abuse and Addiction Research Programs, National
Institutes of Health, HHS)
Dated: February 3, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-02403 Filed 2-6-20; 8:45 am]
BILLING CODE 4140-01-P
